Anika Therapeutics Stock
Price
Target price
€24.00
€24.00
-1.640%
-0.4
-1.640%
€26.58
24.04.24 / Frankfurt
WKN: 889120 / Symbol: ANIK / Name: Anika / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Anika Therapeutics Stock
We can see a decrease in the price for Anika Therapeutics. Compared to yesterday it has lost -€0.400 (-1.640%).
Currently there is a rather positive sentiment for Anika Therapeutics with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 26 € shows a slightly positive potential of 8.33% compared to the current price of 24.0 € for Anika Therapeutics.
Pros and Cons of Anika Therapeutics in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Anika Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Anika Therapeutics | -1.640% | 0.000% | 2.564% | 0.000% | 17.647% | -32.203% | -16.724% |
Ardelyx Inc. | -2.390% | -2.578% | -17.883% | 40.048% | 2.007% | -13.927% | - |
Salarius Pharmaceuticals Inc. | -3.170% | -2.727% | -46.500% | -69.209% | -22.883% | -98.244% | -99.994% |
Brainstorm Cell | 1.170% | 3.754% | -21.032% | -81.975% | 114.440% | -80.717% | - |
Comments
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at Barrington Research from a "market perform" rating to an "outperform" rating.
Show more
Ratings data for ANIK provided by MarketBeat